Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Department of Gastroenterology and Hepatology, Saiseikai Nakatsu Hospital, Osaka, Japan.
Sci Rep. 2018 Jun 11;8(1):8829. doi: 10.1038/s41598-018-27200-y.
Severe acute pancreatitis is a lethal inflammatory disease frequently accompanied by pancreatic necrosis. We aimed to identify a key regulator in the development of pancreatic necrosis. A cytokine/chemokine array using sera from patients with acute pancreatitis (AP) revealed that serum CXCL16 levels were elevated according to the severity of pancreatitis. In a mouse model of AP, Cxcl16 expression was induced in pancreatic acini in the late phase with the development of pancreatic necrosis. Cxcl16 mice revealed similar sensitivity as wild-type (WT) mice to the onset of pancreatitis, but better resisted development of acinar cell necrosis with attenuated neutrophil infiltration. A cytokine array and immunohistochemistry revealed lower expression of Ccl9, a neutrophil chemoattractant, in the pancreatic acini of Cxcl16 mice than WT mice. Ccl9 mRNA expression was induced by stimulation with Cxcl16 protein in pancreatic acinar cells in vitro, suggesting a Cxcl16/Ccl9 cascade. Neutralizing antibody against Cxcl16 ameliorated pancreatic injury in the mouse AP model with decreased Ccl9 expression and less neutrophil accumulation. In conclusion, Cxcl16 expressed in pancreatic acini contributes to the development of acinar cell necrosis through the induction of Ccl9 and subsequent neutrophil infiltration. CXCL16 could be a new therapeutic target in AP.
重症急性胰腺炎是一种致命的炎症性疾病,常伴有胰腺坏死。我们旨在确定胰腺坏死发展中的关键调节因子。使用急性胰腺炎(AP)患者的血清进行细胞因子/趋化因子分析显示,根据胰腺炎的严重程度,血清 CXCL16 水平升高。在 AP 的小鼠模型中,Cxcl16 在胰腺坏死发生的后期在胰腺腺泡中诱导表达。Cxcl16 小鼠与野生型(WT)小鼠一样对胰腺炎的发作具有相似的敏感性,但通过减弱中性粒细胞浸润,更好地抵抗腺泡细胞坏死的发展。细胞因子分析和免疫组织化学显示,Cxcl16 小鼠胰腺腺泡中的趋化因子 Ccl9 的表达低于 WT 小鼠。在体外,Cxcl16 蛋白刺激胰腺腺泡细胞诱导 Ccl9 mRNA 表达,表明存在 Cxcl16/Ccl9 级联反应。针对 Cxcl16 的中和抗体可改善小鼠 AP 模型中的胰腺损伤,降低 Ccl9 表达和减少中性粒细胞聚集。总之,胰腺腺泡中表达的 Cxcl16 通过诱导 Ccl9 及其随后的中性粒细胞浸润,促进腺泡细胞坏死的发展。CXCL16 可能成为 AP 的新治疗靶点。